Inception Return
(6/16/2023)
|
7.15 %
|
|
YTD Return
|
-4.17 %
|
|
NAVPS
(4/10/2026)
|
$12.23
|
|
Change
|
($0.11) / -0.90 %
|
|
|
Growth of $10,000
(As of March 31, 2026)
|
|
MER
|
1.97 %
|
|
Assets ($mil)
|
$33.05
|
|
Rank (1Yr)
|
15/50
|
|
Std Dev (3Yr)
|
-
|
|
Volatility Ranking (3Yr)
|
-
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Back Fee Only
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
This fund’s objective is to increase the value of your investment over the long term by investing primarily in companies that operate in, or are expected to benefit from, health care related businesses from around the world.
|
Fund Manager
BMO Investments Inc.
Portfolio Manager
Jeff Elliott, BMO Asset Management Inc.
Carmen Tang, BMO Asset Management Inc.
Sub-Advisor
-
|
|
Asset Allocation
(As of March 31, 2026)
|
Sector Allocation
(As of March 31, 2026)
|
Geographic Allocation
(As of March 31, 2026)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Eli Lilly and Co | US Equity | Healthcare | United States | 9.43% |
| Johnson & Johnson | US Equity | Healthcare | United States | 8.65% |
| AstraZeneca PLC | International Equity | Healthcare | European Union | 6.46% |
| Merck & Co Inc | US Equity | Healthcare | United States | 4.86% |
| Abbvie Inc | US Equity | Healthcare | United States | 4.85% |
| Ucb SA | International Equity | Healthcare | European Union | 4.79% |
| McKesson Corp | US Equity | Consumer Services | United States | 4.19% |
| Novartis AG Cl N | International Equity | Healthcare | Other European | 3.98% |
| argenx SE - ADR | International Equity | Healthcare | European Union | 3.96% |
| Thermo Fisher Scientific Inc | US Equity | Healthcare | United States | 3.54% |
Performance Data
(As of March 31, 2026)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-5.98
|
-4.17
|
7.50
|
-4.17
|
3.47
|
-
|
-
|
-
|
|
Benchmark
|
-6.17
|
-2.73
|
4.77
|
-2.73
|
2.29
|
6.57
|
6.28
|
9.03
|
|
Quartile Ranking
|
2
|
2
|
1
|
2
|
2
|
-
|
-
|
-
|
|
Calendar Return (%)
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|
Fund
|
12.96
|
10.50
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Benchmark
|
9.64
|
9.95
|
1.42
|
-1.72
|
15.28
|
13.59
|
17.06
|
11.82
|
14.01
|
-8.68
|
|
Quartile Ranking
|
1
|
2
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|